WallStreetZenWallStreetZen

NASDAQ: SLN
Silence Therapeutics PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SLN

Based on 3 analysts offering 12 month price targets for Silence Therapeutics PLC.
Min Forecast
$49.00+162.88%
Avg Forecast
$59.67+220.1%
Max Forecast
$75.00+302.36%

Should I buy or sell SLN stock?

Based on 3 analysts offering ratings for Silence Therapeutics PLC.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SLN stock forecasts and price targets.

SLN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-30
lockedlocked$00.00+00.00%2024-08-16
lockedlocked$00.00+00.00%2024-06-28Find Out Why

1 of 1

Forecast return on equity

Is SLN forecast to generate an efficient return?
Company
-215.8%
Industry
-752.51%
Market
49.24%
SLN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SLN forecast to generate an efficient return on assets?
Company
-128.71%
Industry
26.49%
SLN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SLN earnings per share forecast

What is SLN's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$1.55
Avg 2 year Forecast
-$1.38
Avg 3 year Forecast
-$0.94

SLN revenue forecast

What is SLN's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$26.9M+18.65%
Avg 2 year Forecast
$40.6M+79.37%
Avg 3 year Forecast
$20.6M-9.3%
SLN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SLN revenue growth forecast

How is SLN forecast to perform vs Biotechnology companies and vs the US market?
Company
4.51%
Industry
35.81%
Market
9.63%
SLN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SLN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SLN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SLN$18.64$59.67+220.10%Strong Buy
RLAY$6.53$21.11+223.29%Strong Buy
APLT$7.70$12.33+60.17%Strong Buy
ZYME$12.57$15.25+21.32%Strong Buy
MDXG$5.76$11.33+96.75%Strong Buy
View Top Biotech Stocks

Silence Therapeutics Stock Forecast FAQ

Is Silence Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: SLN) stock is to Strong Buy SLN stock.

Out of 3 analysts, 2 (66.67%) are recommending SLN as a Strong Buy, 1 (33.33%) are recommending SLN as a Buy, 0 (0%) are recommending SLN as a Hold, 0 (0%) are recommending SLN as a Sell, and 0 (0%) are recommending SLN as a Strong Sell.

If you're new to stock investing, here's how to buy Silence Therapeutics stock.

What is SLN's earnings growth forecast for 2024-2026?

(NASDAQ: SLN) Silence Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.7%.

Silence Therapeutics's earnings in 2024 is -$51,410,256.On average, 4 Wall Street analysts forecast SLN's earnings for 2024 to be -$217,674,362, with the lowest SLN earnings forecast at -$293,036,662, and the highest SLN earnings forecast at -$178,065,340. On average, 3 Wall Street analysts forecast SLN's earnings for 2025 to be -$193,951,011, with the lowest SLN earnings forecast at -$319,676,358, and the highest SLN earnings forecast at -$8,412,536.

In 2026, SLN is forecast to generate -$131,796,393 in earnings, with the lowest earnings forecast at -$351,924,412 and the highest earnings forecast at $207,509,215.

What is SLN's revenue growth forecast for 2024-2026?

(NASDAQ: SLN) Silence Therapeutics's forecast annual revenue growth rate of 4.51% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.63%.

Silence Therapeutics's revenue in 2024 is $22,950,000.On average, 4 Wall Street analysts forecast SLN's revenue for 2024 to be $3,769,517,056, with the lowest SLN revenue forecast at $2,348,499,561, and the highest SLN revenue forecast at $4,702,607,479. On average, 4 Wall Street analysts forecast SLN's revenue for 2025 to be $5,698,791,919, with the lowest SLN revenue forecast at $9,814,625, and the highest SLN revenue forecast at $15,530,943,065.

In 2026, SLN is forecast to generate $2,881,573,909 in revenue, with the lowest revenue forecast at $8,412,536 and the highest revenue forecast at $5,184,926,194.

What is SLN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SLN) forecast ROA is -128.71%, which is lower than the forecast US Biotechnology industry average of 26.49%.

What is SLN's Price Target?

According to 3 Wall Street analysts that have issued a 1 year SLN price target, the average SLN price target is $59.67, with the highest SLN stock price forecast at $75.00 and the lowest SLN stock price forecast at $49.00.

On average, Wall Street analysts predict that Silence Therapeutics's share price could reach $59.67 by Aug 30, 2025. The average Silence Therapeutics stock price prediction forecasts a potential upside of 220.1% from the current SLN share price of $18.64.

What is SLN's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: SLN) Silence Therapeutics's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that SLN's EPS will be -$1.55 for 2024, with the lowest EPS forecast at -$2.09, and the highest EPS forecast at -$1.27. On average, analysts forecast that SLN's EPS will be -$1.38 for 2025, with the lowest EPS forecast at -$2.28, and the highest EPS forecast at -$0.06. In 2026, SLN's EPS is forecast to hit -$0.94 (min: -$2.51, max: $1.48).

What is SLN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SLN) forecast ROE is -215.8%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.